Acceptance of Asthma Pharmacogenetic Study by Children and Adults

Ann Chen Wu1, Robert Davis, Kelan Tantisira

  • 1Center for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ; Department of Pediatrics, Children's Hospital, Boston, MA ; Kaiser Permanente South East, Atlanta, GA.

Journal of Pharmacogenomics & Pharmacoproteomics
|April 6, 2013
PubMed

Insights

Pediatric and adult asthma patients are willing to participate in genetic studies. Buccal smear collection is preferred over blood draws for biospecimen donation in pharmacogenetic research.

Area of Science:

  • Pharmacogenetics
  • Genomic Medicine
  • Pediatric Research

Background:

  • Pharmacogenetic testing holds promise for personalized medicine by tailoring drug prescriptions to individual genetic profiles.
  • Validation in diverse, real-world populations, including children, is crucial for the widespread adoption of pharmacogenetic tests.
  • Limited data exists on the willingness of pediatric populations to provide samples for genetic studies compared to adults.

Purpose of the Study:

  • To determine the willingness of pediatric and adult persistent asthma patients to donate specimens for DNA extraction and genetic research.
  • To compare patient preference and acceptance of blood versus buccal smear specimen collection methods for genetic studies.

Main Methods:

  • A study involving 644 persistent asthma patients (ages 4-38) with high inhaled corticosteroid use.
  • Randomization of 60% of subjects to provide blood specimens and 40% to provide buccal smear specimens.
  • Informed consent, phone surveys, and specimen collection conducted by research assistants.

Main Results:

  • Buccal smear collection was more readily accepted than blood draws (30% vs. 16% sample provision).
  • Pediatric subjects showed a higher willingness to provide specimens (23%) compared to adult subjects (15%).
  • Buccal smear group showed higher likelihood of providing specimens (RR 1.21) compared to blood group.

Conclusions:

  • Pediatric and adult asthma patients exhibit comparable willingness to participate in genetic research.
  • Both pediatric and adult participants show a preference for buccal smear collection over blood draws for genetic studies.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...